High content screening for neurodegenerative drug discovery enables multiparametric analysis of neuronal cells to identify therapeutic candidates. By combining automated imaging with advanced data analysis, researchers can assess cell morphology, protein localization, and synaptic activity. This approach supports high-throughput evaluation of neurotoxicity, regeneration, and signaling pathways, accelerating the development of treatments for CNS disorders.
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek